Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: Relevance to oxidative stress

Atherosclerosis

Volumn 210, Issue 2, 2010, Pages 607-613

  Giral, Philippe ^a,b   Ratziu, Vlad ^a   Couvert, Philippe ^b,c   Carrié, Alain ^b,c   Kontush, Anatol ^b   Girerd, Xavier ^a,b   Chapman, M John ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Bilirubin; Gamma glutamyltransferase; Metabolic syndrome; Oxidation

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; ATHEROSCLEROSIS; BILIRUBIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN;

EID: 77953231955     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.026     Document Type: Article

References (29)

1. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996, 16:250-255. 4.
2. Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112:2130-2137. Vorarlberg Health Monitoring and Promotion Program Study Group.
3. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
4. Lim J.S., Yang J.H., Chun B.Y., et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?. Free Radic Biol Med 2004, 37:1018-1023.
5. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-1046.
6. Bruckert E., Giral P., Ratziu V., et al. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism 2002, 51:1071-1076.
7. Giral P., Jacob N., Dourmap C., et al. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:587-593.
8. Hansel B., Giral P., Nobecourt E., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004, 89:4963-4971.
9. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
10. Klauke R., Schmidt E., Lorentz K. Recommendations for carrying out standard ECCLS procedures (1988) for the catalytic concentrations of creatine kinase, aspartate aminotransferase, alanine aminotransferase and gamma-glutamyltransferase at 37°. Eur J Clin Chem Clin Biochem 1993, 31:901-909.
11. Piton A., Poynard T., Imbert-Bismut F., et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology 1998, 27:1213-1219. MULTIVIRC Group.
12. Altman D.G. Practical statistics for medical research 1991, Chapman and Hall.
13. Breitling L.P., Raum E., Müller H., Rothenbacher D., Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009, 49:802-808.
14. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Int Med 2004, 164:1066-1076.
15. Onat A., Hergenc G., Karabulut A., et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 2006, 43:136-139.
16. Stranges S., Dorn J.M., Muti P., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 2004, 39:754-763.
17. Andre P., Balkau B., Born C., Charles M.A., Eschwege E. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 2006, 49:2599-2603. D.E.S.I.R. study group.
18. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38:263-355.
19. Paolicchi A., Emdin M., Ghliozeni E., et al. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004, 109:1440-1441.
20. Wannamethee G., Ebrahim S. Shaper AG gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995, 142:699-708.
21. Sheehan M., Haythorn P. Predictive values of various liver function tests with respect to the diagnosis of liver disease. Clin Biochem 1979, 12:262-263.
22. Lin J.P., O'Donnell C.J., Schwaiger J.P., et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006, 114:1476-1481.
23. Ishizaka N., Ishizaka Y., Toda E., Nagai R., Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005, 25:1038-1044.
24. Tomaro M.L., Batlle A.M. Bilirubin: its role in cytoprotection against oxidative stress. Int J Biochem Cell Biol 2002, 34:216-220.
25. Wiedemann M., Kontush A., Finckh B., Hellwege H.H., Kohlschütter A. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res 2003, 53:843-849.
26. Wu T.W., Fung K.P., Wu J., Yang C.C., Weisel R.D. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 1996, 51:859-862.
27. Torgerson J.S., Lindroos A.K., Sjostrom C.D., et al. Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?. Obes Res 1997, 5:105-111.
28. Sedlak T.W., Saleh M., Higginson D.S., et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 2009, 106:5171-5176.
29. Li M., Kim D.H., Tsenovoy P.L., et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008, 57:1526-1535.